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Skin color has been a fascinating topic throughout human
history, but even as late as the 17th century, explanations
consisted of myths and imaginative accounts implicating
divine intervention or associating dark constitutive pigmen-
tation with intense sun and heat exposure. Well into the 20th
century, little progress had been made in understanding the
pigmentary process, although the finding in 1840 that the
epidermis is composed of cells laid the foundation for more
fruitful research. In 1946, at the First Pigment Cell
Conference, data were presented that only DOPA-positive
epidermal ‘‘melanoblasts’’ produce melanin and that the
pigment is then transferred into surrounding cells (Masson,
1948). Since then, great progress has been made in our
understanding of cutaneous pigmentation, and one of the
pioneers was no doubt Dr Thomas B. Fitzpatrick. He made
excellent use of the research tools then available—
conventional biochemistry and the recently introduced
electron microscope—and laid the foundation for subse-
quent advances largely employing molecular biology ap-
proaches. The following sections review Fitzpatrick’s major
contributions to the field—the central roles of tyrosinase
and a-melanocyte stimulating hormone (a-MSH) in human
pigmentation, identification of the melanosome as the
pigmentary organelle, and the concept of the epidermal
melanin unit—and briefly summarize more recent work in
these key areas.
Melanogenic Enzymes
The pathway for melanin biosynthesis in invertebrates was
well established by 1917, but vertebrate melanogenesis
was riddled with controversies until mid-century. At that
time, Fitzpatrick together with Aaron Lerner, in a series of
seminal publications, identified tyrosine as the precursor
molecule for melanin biosynthesis in mammals and showed
that the enzyme tyrosinase is present in human skin and
catalyzes the first two steps in melanin biosynthesis (Lerner
et al, 1949, 1951; Fitzpatrick et al, 1950; Lerner, 1999).
It was later found that the gene encoding tyrosinase
belongs to a family of at least three genes thought to be
duplications of the original tyrosinase gene (reviewed in
Nordlund et al, 1998). Their products are enzymes that
participate in the later steps of eumelanin biosynthesis:
tyrosinase related protein (TRP)-1 (b-locus protein/gp75)
and TRP-2 (DCT/slaty locus protein). TRP-1 and TRP-2 act
as DHICAoxidase and DOPAchrome tautomerase, respec-
tively, and in vivo appear to be complexed together with
tyrosinase. TRP-1 and TRP-2 share 40% amino acid
homology with tyrosinase and the divergence of TRP-1
and TRP-2 genes from tyrosinase gene is thought to have
occurred prior to mammalian evolution, as these enzymes
are present in all mammals studied to date. TRP-1 and TRP-2
appear to stabilize tyrosinase, optimizing its enzymatic
activity and influencing melanogenic protein trafficking
(Nordlund et al, 1998). In the years since Fitzpatrick demon-
strated a central role for tyrosinase in human pigmentation,
the cloning of tyrosinase has permitted identification of
multiple specific mutations leading to the disease albinism
(Nordlund et al, 1998; Oetting, 2000), and geneticists have
identified more than 100 genes whose protein products
modulate the melanogenic process in ways other than
directly catalyzing melanin synthesis (Nordlund et al, 1998;
Halaban et al, 2003).
Melanosomes
In a series of elegant experiments with Makoto Seiji,
Fitzpatrick showed that tyrosinase is incorporated into
special pigment granules that gradually melanize, and he
coined the term ‘‘melanosomes’’ for them (Seiji et al, 1961).
Subsequent studies have further characterized these
lysosome-related organelles. At the earliest stage of
melanosome development, tyrosinase is incorporated.
Melanocytes also synthesize chaperone proteins, including
calnexin and calreticulin, that specifically bind to glycopro-
teins such as tyrosinase and assure their appropriate folding
and assembly (reviewed in Halaban et al, 2003). Tyrosinase,
TRP-1 and TRP-2, as well as other melanosome-specific
proteins like Pmel 17 (sliver protein/gp100) and the lyso-
some associated membrane protein-1 (LAMP-1) are then
transported to the melanosomes, packaged in transport
vesicles. A short cytoplasmic tail on these proteins contain-
ing a di-leucine motif protrudes from the vesicle surface and
is recognized by a cargo protein complex (AP-3) that directs
them into the melanosomes (Halaban et al, 2003).
Abbreviations: DAG, diacylglycerol; ET, endothelins; bFGF/FGF2,
fibroblast growth factor; LAMP-1, lysosome associated membrane
protein-1; MC1-R, melanocortin-1 receptor; MSH, melanocyte
stimulating hormone; MITF, microphthalmia-associated transcrip-
tion factor; NGF, nerve growth factor; SNARE, N-ethylmaleimide-
sensitive factor attachment protein receptors; POMC, proopiome-
lanocrtin; PAR-2, protease activated receptor 2; PKC protein
kinase C; TRP, tyrosinase related protein; UV, ultraviolet.
Copyright r 2004 by The Society for Investigative Dermatology, Inc.
xxvii
Regulation of Tyrosinase Transcription
and Activation
Following Fitzpatrick’s identification of the importance of
tyrosinase, others elucidated the control of tyrosinase
expression and activation. The tyrosinase promoter was
cloned and it was found that a short sequence of 115 bp
contained all three elements necessary to positively
regulate the transcription of the gene: M-box, Sp-1 site
and E-box (Nordlund et al, 1998). The M-box is an
evolutionarily conserved 11 bp sequence that is bound by
the microphthalmia-associated transcription factor (MITF), a
factor belonging to the family of basic helix-loop-helix
leucine-zipper transcription factors (Yasumoto et al, 1994).
Interestingly, the promoters of TRP-1 and TRP-2 also
contain an M-box and an E-box. cAMP through the cAMP
dependent-protein kinase A pathway up-regulates tyrosi-
nase, TRP-1 and TRP-2 transcription through the M-box
and the E-box that are present in their promoters. These
effects are mediated, at least in part, through MITF as cAMP
induces MITF transcription and enhances MITF binding to
its consensus sequence in the promoter (Bertolotto et al,
1998). The ubiquitous Sp-1 transcription factor is thought to
control the constitutive level of tyrosinase expression.
Recognition that tyrosinase transcription is also up-regu-
lated by the tumor suppressor protein p53 (Nylander et al,
2000; Khlgatian et al, 2002) further validated the clinically
appreciated role of melanin pigmentation in preventing
UV-induced epidermal injury and specifically photocarcino-
genesis. Indeed, recent work identifies enhanced melano-
genesis as an integral part of the cellular response to DNA
damage (Gilchrest and Eller, 2001).
It gradually became apparent that tyrosinase mRNA and
protein levels did not alone dictate tyrosinase activity, which
in turn determines the rate of melanogenesis. Work has
identified tyrosinase as a phosphoprotein requiring activa-
tion by the protein kinase C (PKC) pathway (Park et al,
1993). Delayed tanning, a photoprotective cutaneous
response to UV irradiation, appears within 3–4 days after
a single UV exposure and clinically parallels increased
tyrosinase activity in melanocytes. UV-irradiation disrupts
cellular membranes, cleaving the lipid bilayer to release the
molecule diacylglycerol (DAG), which is the secondary
messenger similarly released by growth factor or cytokine
binding to cell surface receptors. DAG then activates the
enzyme protein kinase C (PKC) that phosphorylates
proteins on serine/threonine residues. It was found that
activation of the b isoform of PKC specifically phospho-
rylates two serine residues in the cytoplasmic domain of
tyrosinase (Park et al, 1999), a transmembrane protein with
a ‘‘tail’’ that projects outside the melanosome, and this
phosphorylation event is required for melanogenesis (re-
viewed in Nordlund et al, 1998).
Melanocortins and their Receptors
As early as 1912 it was known that factors present in bovine
pituitary extract can darken frog skin (reviewed in Nordlund
et al, 1998). However, in 1954 Drs Lerner and Fitzpatrick
were the first to name the activity ‘‘melanocyte stimulating
hormone’’ (MSH) and to show that when injected into
humans, MSH produces skin darkening (Lerner et al, 1954).
Since then, the melanocortins, a group of peptides derived
from a precursor protein proopiomelanocortin (POMC),
have been thoroughly characterized. Differential processing
of POMC, a molecule now known to be produced not only in
the pituitary but also in other tissues including the skin,
gives rise to several peptides including g-MSH, a-MSH,
b-MSH, ACTH, g-lipotropin and b-endorphin. Melanocortins
bind their specific receptors, a family of G-protein-coupled
seven-membrane spanning molecules (Nordlund et al,
1998). a-MSH, by binding its cognate melanocortin-1
receptor (MC1-R), activates adenylate cyclase, elevating
intracellular cAMP levels and leading to tyrosinase, TRP-1
and TRP-2 transcription. Interestingly, it was found that
loss-of-function-mutations in MC1-R characterize indivi-
duals with red and blond hair, implying that the synthesis of
eumelanin versus phaeomelanin is regulated through MC1-
R (reviewed in Rees, 2000). At least in mice and likely also in
humans, the action of a-MSH on MC1-R can be competi-
tively inhibited by the agouti protein that occupies but does
not activate the receptor (Willard et al, 1995).
The Epidermal Melanin Unit
Fitzpatrick and Breathnach (1963) first coined the term
‘‘epidermal melanin unit’’ to describe a single basilar
melanocyte surrounded by the epidermal cells, specifically
keratinocytes (36 in their estimate), to which it supplies
melanin. Fitzpatrick and Lerner also suggested the use of
the term ‘‘melanocyte’’ to describe pigment producing cells
of higher vertebrates, compared to the term ‘‘melanophore’’
for analogous cells in lower vertebrates, and eliminating the
previously used term ‘‘melanoblast’’ that implied an un-
differentiated state (Fitzpatrick et al, 1966; Lerner, 2004). It
has since become evident that there is extensive cross-talk
between keratinocytes and melanocytes and that keratino-
cytes affect melanocyte proliferation, melanogenesis and
dendricity via paracrine stimulation. Not surprisingly, the
majority of these keratinocyte-derived signals are induced
by UV irradiation (reviewed in Nordlund et al, 1998; Halaban
et al, 2003). These include basic fibroblast growth factor
(bFGF/FGF2) (Halaban et al, 1988), endothelin (ET-1)
(Imokawa et al, 1992), a-MSH (Bhardwaj and Luger, 1994),
and nerve growth factor (NGF) (Yaar et al, 1991). Acting
through their cognate receptors on the melanocyte surface,
these and other keratinocyte-derived factors variously
modulate cAMP levels; increase tyrosinase gene transcrip-
tion; induce melanocyte proliferation, migration and
dendricity; and enhance melanocyte survival after UV
irradiation.
Movement of melanosomes along melanocyte dendrites
and their eventual transfer to surrounding keratinocytes is
necessary if melanin is to achieve its function of protecting
cells in the skin from UV (and perhaps other) injury. Two
cytoskeletal macromolecule-polymers, actin filaments and
microtubules, direct intracellular transport of cytoplasmic
organelles like melanosomes (reviewed in Marks and Seabra,
2001; Halaban et al, 2003). Melanosomes are transported
along these pathways by small motor proteins: kinesin (Hara
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et al, 2000) and dynein/dynactin (Byers et al, 2000), acting
as short cross-bridge structures connecting the melano-
some to the microtubule; and myosin Va, a member of the
myosin V family, that is the actin filament-based motor
protein (Wu et al, 1998). In addition, linker proteins have
been identified that link the melanosome to myosin Va.
These include the protein Rab27a that encodes a small
GTPase protein and melanophilin, a member of the Rab
family of proteins. Recent data establish that melanosome
movement in dendrites is bi-directional, although net
movement is usually outward. Kinesin promotes antero-
grade transport of melanosomes toward the dendrite tip,
while dynein/dynactin promotes their retrograde movement
toward the nucleus.
Once the melanosomes reach the dendrite tips they are
transferred to keratinocytes where they preferentially
localize above the nucleus forming a ‘‘protective cap’’, a
process that relies on dynein (Byers et al, 2003). Three
distinct modes of melanosome transfer are currently
thought to occur (Marks and Seabra, 2001; Halaban et al,
2003). The first involves phagocytosis of dendrite tips by
surrounding keratinocytes, a process mediated in part
through the protease activated receptor 2 (PAR-2) that is
present on keratinocytes (Seiberg et al, 2000); the second is
through fusion of melanocyte and keratinocyte membranes,
a process mediated in part by N-ethylmaleimide-sensitive
factor attachment protein receptors (SNARE) that are
present on the membranes of the participating cells (Scott
et al, 2002), creating a conduit for melanosomal transfer;
and the third involves exocytosis of melanosomes into the
intercellular space where they are phagocytosed by
keratinocytes (Marks and Seabra, 2001).
Perspectives
Over the past 50 years, our understanding of melanocyte
biology has expanded remarkably. We now appreciate
many of the events within the epidermal melanin unit that
maintain or increase melanocyte number in response to
epidermal injury, affect melanin synthesis, and enhance
melanosome transfer to keratinocytes. This detailed knowl-
edge is based largely on the seminal work of Dr Fitzpatrick
and colleagues, who paved the way for new generations of




Bertolotto C, Abbe P, Hemesath TJ, Bille K, Fisher DE, Ortonne JP, Ballotti R:
Microphthalmia gene product as a signal transducer in cAMP-induced
differentiation of melanocytes. J Cell Biol 142:827–835, 1998
Bhardwaj RS, Luger TA: Proopiomelanocortin production by epidermal cells:
evidence for an immune neuroendocrine network in the epidermis. Arch
Dermatol Res 287:85–90, 1994
Byers HR, Maheshwary S, Amodeo DM, Dykstra SG: Role of cytoplasmic dynein
in perinuclear aggregation of phagocytosed melanosomes and supra-
nuclear melanin cap formation in human keratinocytes. J Invest Dermatol
121:813–820, 2003
Byers HR, Yaar M, Eller MS, Jalbert NL, Gilchrest BA: Role of cytoplasmic dynein
in melanosome transport in human melanocytes. J Invest Dermatol
114:990–997, 2000
Fitzpatrick T, Becker SW, Lerner AB, Montgomery H: Tyrosinase in human skin:
Demonstration of its presence andits role in human melanin formation.
Scien 112:223–225, 1950
Fitzpatrick TB, Quevedo WC, Levene AL Jr, McGovern VJ, Mishima Y, Oettle AG:
Terminology of vertebrate melanin-containing cells. Science 152:88–89,
1966
Gilchrest B, Eller MS: Evidence in man for an evolutionarily conserved protective
adaptation to DNA damage. Comm Theor Biol 6:483–504, 2001
Halaban R, Hebert DN, Fisher DE: Biology of Melanocytes. In: Freedberg IM,
Wolff K, Austen KF, Goldsmith LA, Katz SI (eds). Fitzpatrick’s Dermatology
in General Medicine. New York: McGraw-Hill, 2003; p 127–148
Halaban RR, Langdon N, Birchall C, et al: Paracrine stimulation of melanocytes
by keratinocytes through basic fibroblast growth factor. Ann N YAcad Sci
548:180–190, 1988
Hara M, Yaar M, Byers HR, Goukassian D, Fine RE, Gonsalves J, Gilchrest BA:
Kinesin participates in melanosomal movement along melanocyte
dendrites. J Invest Dermatol 114:438–443, 2000
Imokawa G, Yada Y, Miyagishi M: Endothelins secreted from human keratino-
cytes are intrinsic mitogens for human melanocytes. J Biol Chem
267:24675–24680, 1992
Khlgatian MK, Hadshiew IM, Asawanonda P, et al: Tyrosinase gene expression is
regulated by p53. J Invest Dermatol 118:126–132, 2002
Lerner AB: My 60 years in pigmentation. Pigment Cell Res 12:131–144, 1999
Lerner AB: We came over on the boat together. J Invest Dermatol 122:ix–xii,
2004
Lerner A, Fitzpatrick TB, Calkins E, Summerson WH: Mammalian tyrosinase:
Preparation and properties. J Biol Chem 178:185–195, 1949
Lerner A, Fitzpatrick TB, Calkins E, Summerson WH: Mammalian tyrosinase:
Action on substances structurally related to tyrosinase. J Biol Chem
191:799–806, 1951
Lerner A, Shizume K, Fitzpatrick TB, Mason HS: MSH. The melanocyte
stimulating hormone. AMA Arch Dermatol 70:669–674, 1954
Marks M, Seabra MC: The melanosome. Membrane dynamics in black and white.
Mol Cell Biol 2:1–11, 2001
Masson P: Pigment Cells in Man. In: Miner M G RW (ed). The Biology of
Melanomas, v 4. New York: Academy of Sciences, 1948; p 15–37
Nordlund JJ, Boissy RE, Hearing VJ, King RA, Ortonne J-P: The Pigmentary
System. Physiology and Pathophysiology. New York: Oxford University
Press, 1998
Nylander K, Bourdon JC, Bray SE, Gibbs NK, Kay R, Hart I, Hall PA:
Transcriptional activation of tyrosinase and TRP-1 by p53 links UV
irradiation to the protective tanning response. J Pathol 190:39–46, 2000
Oetting WS: The tyrosinase gene and oculocutaneous albinism type 1 (OCA1): A
model for understanding the molecular biology of melanin formation.
Pigment Cell Res 13:320–325, 2000
Park HY, Perez JM, Laursen R, Hara M, Gilchrest BA: Protein kinase C-beta
activates tyrosinase by phosphorylating serine residues in its cytoplasmic
domain. J Biol Chem 274:16470–16478, 1999
Park HY, Russakovsky V, Ohno S, Gilchrest BA: The beta isoform of protein
kinase C stimulates human melanogenesis by activating tyrosinase in
pigment cells. J Biol Chem 268:11742–11749, 1993
Rees JL: The melanocortin 1 receptor (MC1R): More than just red hair. Pigment
Cell Res 13:135–140, 2000
Scott G, Leopardi S, Printup S, Madden BC: Filopodia are conduits for
melanosome transfer to keratinocytes. J Cell Sci 115:1441–1451, 2002
Seiberg M, Paine C, Sharlow E, Andrade-Gordon P, Costanzo M, Eisinger M,
Shapiro SS: The protease-activated receptor 2 regulates pigmentation via
keratinocyte–melanocyte interactions. Exp Cell Res 254:25–32, 2000
Seiji M, Fitzpatrick TB, Birbeck MSC: The melanosome: A distinctive subcellular
particle of mammalian tyrosinase and the site of melanogenesis. J Invest
Dermatol 36:243–252, 1961
Willard DH, Bodnar W, Harris C, et al: Agouti structure and function:
Characterization of a potent alpha-melanocyte stimulating hormone
receptor antagonist. Biochemistry 34:12341–12346, 1995
Wu X, Bowers B, Rao K, Wei Q, Hammer JA 3rd: Visualization of melanosome
dynamics within wild-type and dilute melanocytes suggests a paradigm
for myosin V function In vivo. J Cell Biol 143:1899–1918, 1998
Yaar M, Grossman K, Eller M, Gilchrest BA: Evidence for nerve growth factor-
mediated paracrine effects in human epidermis. J Cell Biol 115:821–828,
1991
Yasumoto K, Yokoyama K, Shibata K, Tomita Y, Shibahara S: Microphthalmia-
associated transcription factor as a regulator for melanocyte-specific
transcription of the human tyrosinase gene. Mol Cell Biol 14:8058–8070,
1994
MELANOCYTE BIOLOGY xxix122 : 2 FEBRUARY 2004
